Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03014687 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT03014687 · ClinicalTrials.gov record · last posted 2018-08-15

Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions

Study acronym: POET
StatusRecruiting
PhasePhase 4
Started2017-07-01
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 15, 2018 (before its estimated January 2019 completion). Its status may not reflect the trial's current state.
from the ClinicalTrials.gov record
To find out whether oral antibiotics given after transsphenoidal endoscopic surgery for pituitary adenoma improves sinus and nasal symptoms, reduces the incidence of infection (sinusitis), and helps mucosal healing in the nasal passages.

Amendment record 3 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 3 times since 2017-01-05; most recent amendment 2021-10-05. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2021-10-05
Status change Recruiting→Completedv3
Trial Details
NCT Number NCT03014687
Lead Sponsor St. Joseph's Hospital and Medical Center, Phoenix
Collaborators: Thomas Jefferson University, The Cleveland Clinic
Conditions Antibiotics, Pituitary Adenoma
Enrollment 116 participants
Start Date 2017-07-01
Primary Completion 2019-01 (estimated)
Study Completion 2019-07 (estimated)
Updated on ClinicalTrials.gov 2018-08-15